instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Case report: Vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma in a newborn.
To report a case of vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma (RCH) in a newborn.
A five-week-old full-term male with a history of seizures and birth trauma underwent ophthalmology scre... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34381923 | 20,727,695 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case report: Vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma in a newborn.
To report a case of vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma (RCH) in a newborn.
A five-week-old full-term male with a history of seizures and birth trauma underwent ophthalmology scre... | BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34381923 | 20,727,695 | 2021-09 |
What was the administration route of drug 'BEVACIZUMAB'? | Case report: Vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma in a newborn.
To report a case of vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma (RCH) in a newborn.
A five-week-old full-term male with a history of seizures and birth trauma underwent ophthalmology scre... | Other | DrugAdministrationRoute | CC BY-NC-ND | 34381923 | 20,727,695 | 2021-09 |
What was the dosage of drug 'BEVACIZUMAB'? | Case report: Vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma in a newborn.
To report a case of vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma (RCH) in a newborn.
A five-week-old full-term male with a history of seizures and birth trauma underwent ophthalmology scre... | ADMINISTERED TO THE RIGHT EYE | DrugDosageText | CC BY-NC-ND | 34381923 | 20,727,695 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Management of severe epithelial versus fibrous downgrowth following trabeculectomy: Case report and literature review.
To describe the presentation and management of a patient with epithelial versus fibrous downgrowth following trabeculectomy surgery and review relevant literature regarding this complication after intr... | ACETAZOLAMIDE, BEVACIZUMAB, CYCLOPENTOLATE, FLUOROURACIL, PREDNISOLONE ACETATE, TIMOLOL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 34381927 | 20,727,638 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Management of severe epithelial versus fibrous downgrowth following trabeculectomy: Case report and literature review.
To describe the presentation and management of a patient with epithelial versus fibrous downgrowth following trabeculectomy surgery and review relevant literature regarding this complication after intr... | ACETAZOLAMIDE, BEVACIZUMAB, CYCLOPENTOLATE, FLUOROURACIL, PREDNISOLONE ACETATE, TIMOLOL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 34381927 | 20,727,638 | 2021-09 |
What was the administration route of drug 'BEVACIZUMAB'? | Management of severe epithelial versus fibrous downgrowth following trabeculectomy: Case report and literature review.
To describe the presentation and management of a patient with epithelial versus fibrous downgrowth following trabeculectomy surgery and review relevant literature regarding this complication after intr... | Intracorneal | DrugAdministrationRoute | CC BY-NC-ND | 34381927 | 20,727,638 | 2021-09 |
What was the administration route of drug 'FLUOROURACIL'? | Management of severe epithelial versus fibrous downgrowth following trabeculectomy: Case report and literature review.
To describe the presentation and management of a patient with epithelial versus fibrous downgrowth following trabeculectomy surgery and review relevant literature regarding this complication after intr... | Intracorneal | DrugAdministrationRoute | CC BY-NC-ND | 34381927 | 20,727,638 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion induced'. | Congenital toxoplasmosis after adalimumab treatment before pregnancy.
We present a case of congenital toxoplasmosis (TXP) in a woman with Toxoplasma gondii infection more than 6 months before conception. The woman has been treated with adalimumab for ankylosing spondylitis for 4 years until 5 months before conception. ... | ADALIMUMAB | DrugsGivenReaction | CC BY-NC-ND | 34382299 | 19,753,116 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Congenital toxoplasmosis'. | Congenital toxoplasmosis after adalimumab treatment before pregnancy.
We present a case of congenital toxoplasmosis (TXP) in a woman with Toxoplasma gondii infection more than 6 months before conception. The woman has been treated with adalimumab for ankylosing spondylitis for 4 years until 5 months before conception. ... | ADALIMUMAB | DrugsGivenReaction | CC BY-NC-ND | 34382299 | 19,753,128 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Congenital toxoplasmosis after adalimumab treatment before pregnancy.
We present a case of congenital toxoplasmosis (TXP) in a woman with Toxoplasma gondii infection more than 6 months before conception. The woman has been treated with adalimumab for ankylosing spondylitis for 4 years until 5 months before conception. ... | ADALIMUMAB | DrugsGivenReaction | CC BY-NC-ND | 34382299 | 19,753,128 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Congenital toxoplasmosis after adalimumab treatment before pregnancy.
We present a case of congenital toxoplasmosis (TXP) in a woman with Toxoplasma gondii infection more than 6 months before conception. The woman has been treated with adalimumab for ankylosing spondylitis for 4 years until 5 months before conception. ... | ADALIMUMAB | DrugsGivenReaction | CC BY-NC-ND | 34382299 | 19,753,116 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxoplasmosis'. | Congenital toxoplasmosis after adalimumab treatment before pregnancy.
We present a case of congenital toxoplasmosis (TXP) in a woman with Toxoplasma gondii infection more than 6 months before conception. The woman has been treated with adalimumab for ankylosing spondylitis for 4 years until 5 months before conception. ... | ADALIMUMAB | DrugsGivenReaction | CC BY-NC-ND | 34382299 | 19,753,116 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asphyxia'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | PREGABALIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC | 34382380 | 20,114,152 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest discomfort'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | PREGABALIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC | 34382380 | 20,382,694 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest pain'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | PREGABALIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC | 34382380 | 20,382,694 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chills'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | PREGABALIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC | 34382380 | 20,382,694 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug dependence'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | PREGABALIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC | 34382380 | 20,382,694 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | CELECOXIB, PREGABALIN, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY-NC | 34382380 | 20,083,810 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug withdrawal syndrome'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | BROTIZOLAM, PREGABALIN | DrugsGivenReaction | CC BY-NC | 34382380 | 20,089,524 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product misuse'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | CELECOXIB, PREGABALIN | DrugsGivenReaction | CC BY-NC | 34382380 | 19,945,777 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory distress'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | CELECOXIB, PREGABALIN | DrugsGivenReaction | CC BY-NC | 34382380 | 19,945,777 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Suffocation feeling'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | PREGABALIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC | 34382380 | 20,382,694 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Suicide attempt'. | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | BROTIZOLAM, PREGABALIN | DrugsGivenReaction | CC BY-NC | 34382380 | 20,089,524 | 2021-09 |
What was the outcome of reaction 'Anxiety'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 19,945,777 | 2021-09 |
What was the outcome of reaction 'Asphyxia'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 20,114,152 | 2021-09 |
What was the outcome of reaction 'Chest pain'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovering | ReactionOutcome | CC BY-NC | 34382380 | 20,382,694 | 2021-09 |
What was the outcome of reaction 'Cold sweat'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 20,089,524 | 2021-09 |
What was the outcome of reaction 'Drug dependence'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovering | ReactionOutcome | CC BY-NC | 34382380 | 20,382,694 | 2021-09 |
What was the outcome of reaction 'Drug withdrawal syndrome'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 20,066,619 | 2021-09 |
What was the outcome of reaction 'Epigastric discomfort'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 20,089,524 | 2021-09 |
What was the outcome of reaction 'Headache'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 20,089,524 | 2021-09 |
What was the outcome of reaction 'Lacrimation increased'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 20,089,524 | 2021-09 |
What was the outcome of reaction 'Respiratory distress'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovering | ReactionOutcome | CC BY-NC | 34382380 | 19,945,777 | 2021-09 |
What was the outcome of reaction 'Suffocation feeling'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovering | ReactionOutcome | CC BY-NC | 34382380 | 20,382,694 | 2021-09 |
What was the outcome of reaction 'Suicidal ideation'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 20,066,619 | 2021-09 |
What was the outcome of reaction 'Suicide attempt'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 19,945,651 | 2021-09 |
What was the outcome of reaction 'Tremor'? | Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or ... | Recovered | ReactionOutcome | CC BY-NC | 34382380 | 20,089,524 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic kidney disease'. | Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case report.
Contrast-induced nephropathy (CIN) is the impairment of kidney function defined as a serum creatinine increase of 25% or 44 µmol/L compared with baseline, usually occurring 24 to 48 hours after the use of intraven... | GLIMEPIRIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34382462 | 21,020,703 | 2021-08 |
What was the dosage of drug 'GLIMEPIRIDE'? | Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case report.
Contrast-induced nephropathy (CIN) is the impairment of kidney function defined as a serum creatinine increase of 25% or 44 µmol/L compared with baseline, usually occurring 24 to 48 hours after the use of intraven... | 2 MILLIGRAM | DrugDosageText | CC BY-NC | 34382462 | 21,020,703 | 2021-08 |
What was the dosage of drug 'METFORMIN HYDROCHLORIDE'? | Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case report.
Contrast-induced nephropathy (CIN) is the impairment of kidney function defined as a serum creatinine increase of 25% or 44 µmol/L compared with baseline, usually occurring 24 to 48 hours after the use of intraven... | 200 MILLIGRAM | DrugDosageText | CC BY-NC | 34382462 | 21,020,703 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Sympathetic ophthalmia after vitreoretinal surgery: a report of two cases.
Sympathetic ophthalmia (SO) is a panuveitis that usually occurs after trauma to one eye. We describe two cases of SO occurring after 23-gauge vitrectomy. Case 1 involved a 66-year-old woman who underwent pars plana vitrectomy (PPV) for a rhegmat... | METHYLPREDNISOLONE, PRANOPROFEN, PREDNISOLONE ACETATE | DrugsGivenReaction | CC BY-NC | 34382463 | 19,778,843 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteoporosis'. | Sympathetic ophthalmia after vitreoretinal surgery: a report of two cases.
Sympathetic ophthalmia (SO) is a panuveitis that usually occurs after trauma to one eye. We describe two cases of SO occurring after 23-gauge vitrectomy. Case 1 involved a 66-year-old woman who underwent pars plana vitrectomy (PPV) for a rhegmat... | METHYLPREDNISOLONE, PRANOPROFEN, PREDNISOLONE ACETATE | DrugsGivenReaction | CC BY-NC | 34382463 | 19,778,843 | 2021-08 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Sympathetic ophthalmia after vitreoretinal surgery: a report of two cases.
Sympathetic ophthalmia (SO) is a panuveitis that usually occurs after trauma to one eye. We describe two cases of SO occurring after 23-gauge vitrectomy. Case 1 involved a 66-year-old woman who underwent pars plana vitrectomy (PPV) for a rhegmat... | Oral | DrugAdministrationRoute | CC BY-NC | 34382463 | 19,778,843 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal distension'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase increased'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, CALCIUM, HYDROXYCHLOROQUINE, METFORMIN HYDROCHLORIDE, PREDNISOLONE, TRAMADOL | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 19,752,096 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chromaturia'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic kidney disease'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 19,740,479 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypocalcaemia'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Jaundice cholestatic'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 19,752,106 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Jaundice'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver injury'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 19,752,106 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin discolouration'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | ASPIRIN, FLUVASTATIN SODIUM, GLICLAZIDE, METFORMIN HYDROCHLORIDE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the administration route of drug 'METFORMIN HYDROCHLORIDE'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34383728 | 19,740,479 | 2021-08-12 |
What was the outcome of reaction 'Abdominal distension'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Abdominal pain'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Alanine aminotransferase increased'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovered | ReactionOutcome | CC BY-NC-ND | 34383728 | 19,752,096 | 2021-08-12 |
What was the outcome of reaction 'Asthenia'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Chromaturia'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Chronic kidney disease'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Decreased appetite'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Fatigue'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Hypocalcaemia'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Jaundice'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Pruritus'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Skin discolouration'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
What was the outcome of reaction 'Vomiting'? | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
BACKGROUND Fluvastatin, a commonly prescribed statin, is indicated for treatment of hypercholesterolemia in persons at high risk for coronary, cerebrovascular, and peripheral artery disease. However, there have been rare reports of live... | Recovering | ReactionOutcome | CC BY-NC-ND | 34383728 | 20,388,035 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Symptom recurrence'. | Co-occurrence of IgA nephropathy and IgG4-Tubulointersitial nephritis effectively treated with tacrolimus: a case report.
Cases of concurrent immunoglobulin A nephropathy (IgAN) and IgG4-related tubulointerstitial nephritis (IgG4-TIN) are rare and previous case reports have lacked important data. KDIGO suggests a treat... | CANDESARTAN, TACROLIMUS | DrugsGivenReaction | CC BY | 34384379 | 20,149,892 | 2021-08-12 |
What is the weight of the patient? | Co-occurrence of IgA nephropathy and IgG4-Tubulointersitial nephritis effectively treated with tacrolimus: a case report.
Cases of concurrent immunoglobulin A nephropathy (IgAN) and IgG4-related tubulointerstitial nephritis (IgG4-TIN) are rare and previous case reports have lacked important data. KDIGO suggests a treat... | 79 kg. | Weight | CC BY | 34384379 | 20,149,892 | 2021-08-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostate cancer metastatic'. | Metastatic Thyroid Cartilage Lesion from Prostatic Adenocarcinoma on 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography Scan: Case Series.
Prostate cancer usually metastasizes to regional lymph nodes and bone. Laryngeal cartilage metastases are very rare and only few cases have bee... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-SA | 34385791 | 19,850,341 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | ATORVASTATIN, DULAGLUTIDE, EZETIMIBE, FUROSEMIDE, INSULIN GLARGINE, INSULIN LISPRO, METFORMIN HYDROCHLORIDE, PREGABALIN, RANOLAZINE | DrugsGivenReaction | CC BY-NC | 34385826 | 20,091,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetes mellitus inadequate control'. | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | ATORVASTATIN, DULAGLUTIDE, EZETIMIBE, FUROSEMIDE, INSULIN GLARGINE, INSULIN LISPRO, METFORMIN HYDROCHLORIDE, PREGABALIN, RANOLAZINE | DrugsGivenReaction | CC BY-NC | 34385826 | 20,091,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | ATORVASTATIN, DULAGLUTIDE, EZETIMIBE, FUROSEMIDE, INSULIN GLARGINE, INSULIN LISPRO, METFORMIN HYDROCHLORIDE, PREGABALIN, RANOLAZINE | DrugsGivenReaction | CC BY-NC | 34385826 | 20,091,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoglycaemia'. | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | ATORVASTATIN, DULAGLUTIDE, EZETIMIBE, FUROSEMIDE, INSULIN GLARGINE, INSULIN LISPRO, METFORMIN HYDROCHLORIDE, PREGABALIN, RANOLAZINE | DrugsGivenReaction | CC BY-NC | 34385826 | 20,091,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Increased appetite'. | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | ATORVASTATIN, DULAGLUTIDE, EZETIMIBE, FUROSEMIDE, INSULIN GLARGINE, INSULIN LISPRO, METFORMIN HYDROCHLORIDE, PREGABALIN, RANOLAZINE | DrugsGivenReaction | CC BY-NC | 34385826 | 20,091,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic syndrome'. | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | ATORVASTATIN, DULAGLUTIDE, EZETIMIBE, FUROSEMIDE, INSULIN GLARGINE, INSULIN LISPRO, METFORMIN HYDROCHLORIDE, PREGABALIN, RANOLAZINE | DrugsGivenReaction | CC BY-NC | 34385826 | 20,091,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Obesity'. | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | ATORVASTATIN, DULAGLUTIDE, EZETIMIBE, FUROSEMIDE, INSULIN GLARGINE, INSULIN LISPRO, METFORMIN HYDROCHLORIDE, PREGABALIN, RANOLAZINE | DrugsGivenReaction | CC BY-NC | 34385826 | 20,091,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight increased'. | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | ATORVASTATIN, DULAGLUTIDE, EZETIMIBE, FUROSEMIDE, INSULIN GLARGINE, INSULIN LISPRO, METFORMIN HYDROCHLORIDE, PREGABALIN, RANOLAZINE | DrugsGivenReaction | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the administration route of drug 'INSULIN GLARGINE'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Intravenous bolus | DrugAdministrationRoute | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the administration route of drug 'INSULIN LISPRO'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Intravenous bolus | DrugAdministrationRoute | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the dosage of drug 'ATORVASTATIN'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | 40 MILLIGRAM, QD | DrugDosageText | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the dosage of drug 'DULAGLUTIDE'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | 1.5 MILLIGRAM, QW | DrugDosageText | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the dosage of drug 'EZETIMIBE'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | 10 MILLIGRAM, QD | DrugDosageText | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the dosage of drug 'INSULIN GLARGINE'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | 30 INTERNATIONAL UNIT, QD, LONG-ACTING BASAL-BOLUS 30 IU, HS, AT BEDTIME | DrugDosageText | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the dosage of drug 'METFORMIN HYDROCHLORIDE'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | 750 MILLIGRAM, QD | DrugDosageText | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Recovered | ReactionOutcome | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the outcome of reaction 'Diabetes mellitus inadequate control'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Recovered | ReactionOutcome | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the outcome of reaction 'Hyperglycaemia'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Recovered | ReactionOutcome | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the outcome of reaction 'Hypoglycaemia'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Recovering | ReactionOutcome | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the outcome of reaction 'Increased appetite'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Recovered | ReactionOutcome | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the outcome of reaction 'Metabolic syndrome'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Recovered | ReactionOutcome | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the outcome of reaction 'Obesity'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Recovering | ReactionOutcome | CC BY-NC | 34385826 | 20,091,275 | 2021 |
What was the outcome of reaction 'Weight increased'? | When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs.
New antidiabetic drugs have simplified treatment regimens in patients with type-2 diabetes (T2D). More importantly, they have proven to reduce cardiovascular risk by lowering insulin-resista... | Recovering | ReactionOutcome | CC BY-NC | 34385826 | 20,091,275 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Symptomatic spontaneous superior mesenteric artery dissection treated with endovascular stent repair.
Spontaneous isolated superior mesenteric artery dissection (SISMAD) is a rare condition in which patients develop an isolated dissection of the superior mesenteric artery without traumatic or iatrogenic causes. We pres... | HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 34386188 | 20,994,077 | 2021-08 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.